These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35043771)

  • 1. An Updated Review of Epigenetic-Related Mechanisms and their Contribution to Multiple Sclerosis Disease.
    Eslahi M; Nematbakhsh N; Dastmalchi N; Teimourian S; Safaralizadeh R
    CNS Neurol Disord Drug Targets; 2023; 22(3):381-393. PubMed ID: 35043771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic changes in neurology: DNA methylation in multiple sclerosis.
    Iridoy Zulet M; Pulido Fontes L; Ayuso Blanco T; Lacruz Bescos F; Mendioroz Iriarte M
    Neurologia; 2017 Sep; 32(7):463-468. PubMed ID: 25976949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic Modifications and Therapy in Multiple Sclerosis.
    Aslani S; Jafari N; Javan MR; Karami J; Ahmadi M; Jafarnejad M
    Neuromolecular Med; 2017 Mar; 19(1):11-23. PubMed ID: 27382982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential role of epigenetic modifications in the heritability of multiple sclerosis.
    Zhou Y; Simpson S; Holloway AF; Charlesworth J; van der Mei I; Taylor BV
    Mult Scler; 2014 Feb; 20(2):135-40. PubMed ID: 24493701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic changes in patients with multiple sclerosis.
    Koch MW; Metz LM; Kovalchuk O
    Nat Rev Neurol; 2013 Jan; 9(1):35-43. PubMed ID: 23165337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetics of multiple sclerosis: an updated review.
    Küçükali Cİ; Kürtüncü M; Çoban A; Çebi M; Tüzün E
    Neuromolecular Med; 2015 Jun; 17(2):83-96. PubMed ID: 24652042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetics in Multiple Sclerosis.
    Chan VS
    Adv Exp Med Biol; 2020; 1253():309-374. PubMed ID: 32445101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetics and miRNAs in the diagnosis and treatment of multiple sclerosis.
    Koch MW; Metz LM; Kovalchuk O
    Trends Mol Med; 2013 Jan; 19(1):23-30. PubMed ID: 23153574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic aspects of multiple sclerosis and future therapeutic options.
    Jamebozorgi K; Rostami D; Pormasoumi H; Taghizadeh E; Barreto GE; Sahebkar A
    Int J Neurosci; 2021 Jan; 131(1):56-64. PubMed ID: 32075477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comprehensive Examination of the Role of Epigenetic Factors in Multiple Sclerosis.
    Manna I; De Benedittis S; Porro D
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic research in multiple sclerosis: progress, challenges, and opportunities.
    Zheleznyakova GY; Piket E; Marabita F; Pahlevan Kakhki M; Ewing E; Ruhrmann S; Needhamsen M; Jagodic M; Kular L
    Physiol Genomics; 2017 Sep; 49(9):447-461. PubMed ID: 28754822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic modifications in brain and immune cells of multiple sclerosis patients.
    Castro K; Casaccia P
    Mult Scler; 2018 Jan; 24(1):69-74. PubMed ID: 29307300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic mechanisms in multiple sclerosis and the major histocompatibility complex (MHC).
    Burrell AM; Handel AE; Ramagopalan SV; Ebers GC; Morahan JM
    Discov Med; 2011 Mar; 11(58):187-96. PubMed ID: 21447278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic insights into multiple sclerosis disease progression.
    Kular L; Jagodic M
    J Intern Med; 2020 Jul; 288(1):82-102. PubMed ID: 32614160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tale of histone modifications and its role in multiple sclerosis.
    He H; Hu Z; Xiao H; Zhou F; Yang B
    Hum Genomics; 2018 Jun; 12(1):31. PubMed ID: 29933755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interplay between the Epigenetic Enzyme Lysine (K)-Specific Demethylase 2B and Epstein-Barr Virus Infection.
    Vargas-Ayala RC; Jay A; Manara F; Maroui MA; Hernandez-Vargas H; Diederichs A; Robitaille A; Sirand C; Ceraolo MG; Romero-Medina MC; Cros MP; Cuenin C; Durand G; Le Calvez-Kelm F; Mundo L; Leoncini L; Manet E; Herceg Z; Gruffat H; Accardi R
    J Virol; 2019 Jul; 93(13):. PubMed ID: 30996097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic control of the Epstein-Barr lifecycle.
    Guo R; Gewurz BE
    Curr Opin Virol; 2022 Feb; 52():78-88. PubMed ID: 34891084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combinatorial epigenetic deregulation by Helicobacter pylori and Epstein-Barr virus infections in gastric tumourigenesis.
    Wu WK; Yu J; Chan MT; To KF; Cheng AS
    J Pathol; 2016 Jul; 239(3):245-9. PubMed ID: 27102722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Genetic and Epigenetic Basis of Multiple Sclerosis.
    Hojati Z
    Adv Exp Med Biol; 2017; 958():65-90. PubMed ID: 28093709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetics in Multiple Sclerosis: Molecular Mechanisms and Dietary Intervention.
    Rito Y; Torre-Villalvazo I; Flores J; Rivas V; Corona T
    Cent Nerv Syst Agents Med Chem; 2018 Jan; 18(1):8-15. PubMed ID: 26915659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.